Who
Thomas Teisseyre
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Hyperfine.
In numbers
- Trades disclosed
- 24
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $126K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Jul 2023
- Last trade
- 24 Aug 2026
- Last filed
- 25 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Aug 2026filed 25 Aug 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $6,2737,345 at $0.854 | filing |
| 24 Aug 2026filed 25 Aug 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $6,2437,345 at $0.85 | filing |
| 26 May 2026filed 27 May 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $9,9786,047 at $1.65 | filing |
| 26 May 2026filed 27 May 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $9,9786,047 at $1.65 | filing |
| 31 Mar 2026filed 1 Apr 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | —330,000 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | —330,000 at $0.00 | filing |
| 23 Mar 2026filed 25 Mar 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $29K24,188 at $1.21 | filing |
| 23 Mar 2026filed 25 Mar 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $29K24,188 at $1.21 | filing |
| 13 Feb 2026filed 17 Feb 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $913821 at $1.11 | filing |
| 13 Feb 2026filed 17 Feb 2026 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $911821 at $1.11 | filing |
| 19 Nov 2025filed 19 Nov 2025 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $1,5171,405 at $1.08 | filing |
| 18 Aug 2025filed 18 Aug 2025 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $1,5311,151 at $1.33 | filing |
| 16 May 2025filed 16 May 2025 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $1,6102,776 at $0.58 | filing |
| 31 Mar 2025filed 20 May 2025 | HYPR HyperfineMedical Devices | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 20 Feb 2025filed 20 Feb 2025 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $3,4973,238 at $1.08 | filing |
| 18 Feb 2025filed 18 Feb 2025 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $3,8843,237 at $1.20 | filing |
| 18 Nov 2024filed 18 Nov 2024 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $2,3802,800 at $0.85 | filing |
| 16 Aug 2024filed 16 Aug 2024 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $2,8832,746 at $1.05 | filing |
| 16 May 2024filed 16 May 2024 | HYPR HyperfineMedical Devices | SEC FORM 4 Sold | $2,4232,753 at $0.88 | filing |
| 28 Mar 2024filed 28 Mar 2024 | HYPR Hyperfineoption or derivative · Medical Devices | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
News
Critical Review: Beta Bionics (NASDAQ:BBNX) vs. Hyperfine (NASDAQ:HYPR)HYPR · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Thomas Teisseyre; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.